Meanwhile, miR-1298-3p agonist markedly decreased the protein levels of NID1 and vimentin, but increased the protein level of E-cadherin in tumor tissues, compared with NC group (Figure 7H–7K). This evidence concerns the gene CDH1 and neoplasm.